Logo
 
USD 918.68  CAD 1206.53  EUR 860.01  AUD 1217.48  GBP 732.74 
 

Browse Categories

Search Options

Search terms:

Listing type:

All  Fixed Price  Auction

Product type:

All  Digital  Physical

Price range:

USD  to USD

Origin country:

Ships to:

Order by:

Active vendor:

Automatic fulfillment:

Multisig options:

Bulk discounts:

In stock:

Payment type:

Cryptocurrency:

Average vendor processing:

Vendor trust level:

to

Exchange Rates

Bitcoin (BTC)

United States Dollar (USD)
918.68
 
Canadian Dollar (CAD)
1,206.53
 
Euro (EUR)
860.01
 
Australian Dollar (AUD)
1,217.48
 
British Pound (GBP)
732.74
 
Deposits & Withdrawals
 

Monero (XMR)

United States Dollar (USD)
12.41
 
Canadian Dollar (CAD)
16.29
 
Euro (EUR)
11.61
 
Australian Dollar (AUD)
16.44
 
British Pound (GBP)
9.89
 
Deposits & Withdrawals
 

The above rates are updated every 10 minutes and taken using a weighted average of major exchange platforms.

 

ADDERALL 10mg ER $7 each X 20 Pills (Extended Release)

This item is out of stock. You can use the left menu to set an alert when the seller restocks his listing.

Adderall XR extended-release capsules QTY: 20 PILLS PRICE: $7 Indications and Usage for Adderall XR Attention Deficit Hyperactivity Disorder Adderall XR® is indicated for the treatment of attention deficit hyperactivity disorder (ADHD). The efficacy of Adderall XR in the treatment of ADHD was established on the basis of two controlled trials in children aged 6 to 12, one controlled t...

Sold by TEAMTEXAS - 76 sold since May 23, 2016  Vendor Level 9 Trust Level 8

 
Features
 
Product class
Physical package
 
Quantity left
0 items
 
Ends in
Never
 
 
Features
 
Origin country
United States
 
Ships to
United States
 
Payment
FE Listing 100%
 
 

Purchase price: USD 140.00

Qty:  
0.1524 BTC / 11.2812 XMR

 

Product Description

Adderall XR extended-release capsules

QTY: 20 PILLS
PRICE: $7

Indications and Usage for Adderall XR
Attention Deficit Hyperactivity Disorder

Adderall XR® is indicated for the treatment of attention deficit hyperactivity disorder (ADHD).

The efficacy of Adderall XR in the treatment of ADHD was established on the basis of two controlled trials in children aged 6 to 12, one controlled trial in adolescents aged 13 to 17, and one controlled trial in adults who met DSM-IV® criteria for ADHD [see CLINICAL STUDIES (14)].

A diagnosis of ADHD (DSM-IV®) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years. The symptoms must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and be present in two or more settings, e.g., school (or work) and at home. The symptoms must not be better accounted for by another mental disorder. For the Inattentive Type, at least six of the following symptoms must have persisted for at least 6 months: lack of attention to details/careless mistakes; lack of sustained attention; poor listener; failure to follow through on tasks; poor organization; avoids tasks requiring sustained mental effort; loses things; easily distracted; forgetful. For the Hyperactive-Impulsive Type, at least six of the following symptoms must have persisted for at least 6 months: fidgeting/squirming; leaving seat; inappropriate running/climbing; difficulty with quiet activities; "on the go;" excessive talking; blurting answers; can't wait turn; intrusive. The Combined Type requires both inattentive and hyperactive-impulsive criteria to be met.

Special Diagnostic Considerations

Specific etiology of this syndrome is unknown, and there is no single diagnostic test. Adequate diagnosis requires the use not only of medical but of special psychological, educational, and social resources. Learning may or may not be impaired. The diagnosis must be based upon a complete history and evaluation of the patient and not solely on the presence of the required number of DSM-IV® characteristics.

Need for Comprehensive Treatment Program

Adderall XR is indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational, social) for patients with this syndrome. Drug treatment may not be indicated for all patients with this syndrome. Stimulants are not intended for use in the patient who exhibits symptoms secondary to environmental factors and/or other primary psychiatric disorders, including psychosis. Appropriate educational placement is essential and psychosocial intervention is often helpful. When remedial measures alone are insufficient, the decision to prescribe stimulant medication will depend upon the physician's assessment of the chronicity and severity of the child's symptoms.

Long-Term Use

The effectiveness of Adderall XR for long-term use, i.e., for more than 3 weeks in children and 4 weeks in adolescents and adults, has not been systematically evaluated in controlled trials. Therefore, the physician who elects to use Adderall XR for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient.
DOSAGE and ADMINISTRATION
Dosing Considerations for all Patients

Individualize the dosage according to the therapeutic needs and response of the patient. Administer Adderall XR at the lowest effective dosage.

Based on bioequivalence data, patients taking divided doses of immediate-release ADDERALL, (for example, twice daily), may be switched to Adderall XR at the same total daily dose taken once daily. Titrate at weekly intervals to appropriate efficacy and tolerability as indicated.

Adderall XR capsules may be taken whole, or the capsule may be opened and the entire contents sprinkled on applesauce. If the patient is using the sprinkle administration method, the sprinkled applesauce should be consumed immediately; it should not be stored. Patients should take the applesauce with sprinkled beads in its entirety without chewing. The dose of a single capsule should not be divided. The contents of the entire capsule should be taken, and patients should not take anything less than one capsule per day.
Advertisement
Slideshow
Warfarin: 12 Things You Didn't Know About This Blood Thinner

Adderall XR may be taken with or without food.

Adderall XR should be given upon awakening. Afternoon doses should be avoided because of the potential for insomnia.

Where possible, Adderall XR therapy should be interrupted occasionally to determine if there is a recurrence of behavioral symptoms sufficient to require continued therapy.

addy vyvanse adhd adderall speed30mg amphetamine